24 Mar - Sofie Sagvaag Kristensen (KBM)

Norwegian title of thesis:
RseP, en posisjon-2-protease, som et nytt antimikrobielt angrepspunkt.

Prescribed subject of the trial lecture (Approved):
Antibiotic resistance and the void in antibiotic development: what is in the pipeline for future treatment options?
The trial lecture was held on February 27th 2023.

Evaluation committee - trial lecture:
First opponent: Linda Liberg Bergaust, Associate professor, NMBU
Second opponent: Davide Porcellato, Associate professor, NMBU
Committee coordinator: Daniel Straume, Associate professor, NMBU

Time and place for the public defence:
Friday 24th of March, at 12.15.
The defence will be held in Gullvepsen, Bikuben, NMBU

Evaluation committee:
First opponent: Dr. Javier Pizarro-Cerda, Department of Microbiology, Institut Pasteur, France
Second opponent: Professor Marit Otterlei, Department of Medical Microbiology, St. Olav University Hospital, Norway
Committee coordinator: Daniel Straume, Associate professor, NMBU

Supervisors:
Main supervisors:
Researcher Geir Mathiesen, NMBU
Professor Professor Dzung Diep   (2019-2022)

Co-supervisors: 
Associate Professor Morten Kjos, NMBU
Professor Jens Preben Morth, DTU

The doctoral thesis is available for public review.
For those of you who wants access to this please send an email to: phd-kbm@nmbu.no

Thesis number 2023:22; ISSN 1894-6402; ISBN 978-82-575-2052-6

Published 10. mars 2023 - 14:42 - Updated 10. mars 2023 - 14:43